EW: Edwards Lifesciences Corp insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 1 sales totaling $53K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | Officer | $53K | yes |
Institutional ownership (Q2 2026)
1,339 institutions reported holding $46.18B of Edwards Lifesciences Corp on Form 13F (1,293 the quarter before). 141 opened a new position and 101 sold out. Shares held by institutions: +4%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 58,789,433 | $5.32B |
| VANGUARD CAPITAL MANAGEMENT LLC | 37,615,952 | $3.40B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26,411,402 | $2.39B |
| STATE STREET CORP | 26,321,940 | $2.38B |
| JPMORGAN CHASE & CO | 22,783,175 | $2.08B |
| WELLINGTON MANAGEMENT GROUP LLP | 16,827,967 | $1.52B |
| GEODE CAPITAL MANAGEMENT, LLC | 15,437,251 | $1.39B |
| Bank of New York Mellon Corp | 14,084,483 | $1.27B |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,002,965 | $1.18B |
| Ninety One UK Ltd | 12,337,502 | $1.12B |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.